MolNFT v1 · #183355 · protein
Crystal structure of 14-3-3 sigma in complex with 13MER amot-P130 peptide and fragment 41
7NN2: “Crystal structure of 14-3-3 sigma in complex with 13MER amot-P130 peptide and fragment 41”. X-ray diffraction, 3 ligands (K8W, CA, CL). MolNFT v1 #183355 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 7NN2
- Type
- protein
- Length
- 236 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- UniProt
- P31947, Q4VCS5
- Ligands
- K8W, CA, CL
Structure
x-ray diffraction · 2 distinct chains.
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | — | protein | 229 | — | P31947 |
| P | — | protein | 7 | — | Q4VCS5 |
Ligands and binding sites
- K8W · 7-(6-azanyl-5-methyl-pyridin-2-yl)-1-benzothiophene-2-carboximidamide · ligand · chains A
- CA · Calcium ion · metal · chains A
- CL · Chloride ion · ion · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Compared structures
- 7NN2 · Crystal structure of 14-3-3 sigma in complex with 13mer Amot-p130 peptide and fragment 41 · the same entry in another collection · chain A against A, TM-score 1.00
- P31947 · AlphaFold monomer V2.0 prediction for 14-3-3 protein sigma (P31947) · a predicted model of the same protein · chain A against A, TM-score 0.96
- Q4VCS5 · AlphaFold monomer V2.0 prediction for angiomotin (Q4VCS5) · a predicted model of the same protein · chain P against A, TM-score 0.57
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P31947
- Every structure of UniProt Q4VCS5
- Elsewhere: RCSB PDB 7NN2 · PDBe 7NN2 · UniProt P31947 · UniProt Q4VCS5
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.